Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay

Documenti analoghi

• Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA
  di: Delfau-Larue, Marie-Hélène, et al.
  Pubblicazione: (2012)
• Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma
  di: Jordheim, Lars P., et al.
  Pubblicazione: (2015)
• Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
  di: Morel, P., et al.
  Pubblicazione: (1994)
• Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
  di: Dubois, Sydney, et al.
  Pubblicazione: (2019)
• The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
  di: Mareschal, Sylvain, et al.
  Pubblicazione: (2011)